We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ING:NYSEING Group, N.V. Analysis

Data as of 2026-06-08 - not real-time

$29.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ING reported Q1 net income of $1.82 billion and earnings of 0.63 USD per share, comfortably beating expectations. The bank launched a €1 billion share‑buyback program, underscoring confidence in its outlook. With an operating margin of 42 % and profit margin of 34 %, profitability remains robust. A price‑to‑earnings multiple near 12 is well below the industry average of roughly 17, indicating the stock is undervalued. The dividend yield of 4.27 % coupled with a payout ratio under 50 % points to a sustainable payout. Technically, the share price sits above the 20‑day and 200‑day SMAs, confirming a bullish trend. However, the MACD histogram is negative and the signal line is bearish, suggesting short‑term downside pressure. RSI around 48 is neutral, while rising volume signals growing market interest. Current support at $29.21 and resistance near $31.40 imply a modest upside of about 6 %. A beta above 1 and 30‑day volatility exceeding 30 % highlight higher market sensitivity. The CET1 capital ratio stands at 13 %, satisfying regulatory requirements and mitigating capital risk. Overall, solid fundamentals, an attractive dividend, and limited upside support a cautious buy stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near immediate support level
  • bearish MACD signal
  • elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued valuation relative to peers
  • strong dividend yield and payout sustainability
  • share‑buyback program enhancing shareholder return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • solid CET1 capital ratio
  • consistent earnings and profit margins
  • sustainable dividend supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth2.90%
Profit Margin34.23%
P/E Ratio11.7
ROE16.57%
ROA0.78%
P/B Ratio1.4
Industry P/E17.0

Technical Analysis

TrendBullish
RSI47.6
Support$29.21
Resistance$31.40
MA 20$30.31
MA 50$28.88
MA 200$27.16
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Target Price$31.47
Upside/Downside6.06%
GradeUndervalued
TypeValue
Dividend Yield4.27%

Risk Assessment

Beta1.29
Volatility31.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.